BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27487132)

  • 1. YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma.
    Chang RM; Pei L; Fang F; Xu JF; Yang H; Zuo CH; Zhou JH; Luo GQ; Yang LY
    Oncotarget; 2016 Aug; 7(34):55585-55600. PubMed ID: 27487132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
    Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
    Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of RhoC gene in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Huang GW; Lu WQ
    World J Gastroenterol; 2003 Sep; 9(9):1950-3. PubMed ID: 12970882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
    Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
    Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overexpression of the RhoC gene correlates with invasion and metastasis of hepatocellular carcinoma].
    Wang W; Yang LY; Huang GW; Yang ZL; Lu WQ; Peng JX; Yang JQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):279-82. PubMed ID: 15312362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of RhoC protein in human primary hepatocellular carcinoma and its clinical significance].
    Cai XJ; Xu GG; Shen B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):394-6. PubMed ID: 16924703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients.
    Ng L; Kwan V; Chow A; Yau TC; Poon RT; Pang R; Law WL
    BMC Cancer; 2019 Jul; 19(1):713. PubMed ID: 31324164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
    Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
    Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
    Ma W; Wong CC; Tung EK; Wong CM; Ng IO
    Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.
    Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin-induced degradation of RhoC suppresses hepatocellular carcinoma invasion and metastasis.
    Huang C; Lai W; Mao S; Song D; Zhang J; Xiao X
    Cancer Med; 2024 Feb; 13(4):e7082. PubMed ID: 38457248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma.
    Tao X; Zuo Q; Ruan H; Wang H; Jin H; Cheng Z; Lv Y; Qin W; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):263-276. PubMed ID: 30883650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.
    Wong CC; Wong CM; Tung EK; Man K; Ng IO
    Hepatology; 2009 May; 49(5):1583-94. PubMed ID: 19205033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.